Pliant Therapeutics' GAAP loss for 2021 was $97.263 million, up 2.3 times from $41.533 million in the previous year. Revenue decreased 5.3 times to $7.572 million from $41.817 million a year earlier.
Pliant Therapeutics' GAAP loss for 2021 was $97.263 million, up 2.3 times from $41.533 million in the previous year. Revenue decreased 5.3 times to $7.572 million from $41.817 million a year earlier. 
ir.pliantrx.com
English (US) 